Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib
Author:
Funder
Natural Science Foundation of Shanghai
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-019-03064-1.pdf
Reference20 articles.
1. Asai N, Ohkuni Y, Kaneko N, Yamaguchi E, Kubo A (2014) Relapsed small cell lung cancer: treatment options and latest developments. Ther Adv Med Oncol 6:69–82. https://doi.org/10.1177/1758834013517413
2. Byers LA, Rudin CM (2015) Small cell lung cancer: where do we go from here? Cancer 121:664–672. https://doi.org/10.1002/cncr.29098
3. Crabb SJ et al (2009) Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer. J Clin Oncol 27:404–410. https://doi.org/10.1200/JCO.2008.16.2545
4. Gong J, Salgia R (2018) Managing patients with relapsed small-cell lung cancer. J Oncol Pract 14:359–366. https://doi.org/10.1200/JOP.18.00204
5. Han B et al (2018) Effect of anlotinib as a third-line or further treatment on overall survival of patients with advanced non-small cell lung cancer: the ALTER 0303 phase 3 randomized clinical trial. JAMA Oncol 4:1569–1575. https://doi.org/10.1001/jamaoncol.2018.3039
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Modified response evaluation criteria in solid tumors: A better response evaluation criteria for patients with non‐squamous non‐small cell lung cancer after bevacizumab treatment;Asia-Pacific Journal of Clinical Oncology;2023-10-29
2. Effect of anlotinib combined with ticeorgio for recurrent nasopharyngeal carcinoma: a case report;Frontiers in Pharmacology;2023-07-14
3. Inflammation‐based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy;Journal of Clinical Laboratory Analysis;2022-11-28
4. Anlotinib as third- or further-line therapy for short-term relapsed small-cell lung cancer: subgroup analysis of a randomized phase 2 study (ALTER1202);Frontiers of Medicine;2022-07-16
5. The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis;Tumori Journal;2022-05-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3